NCT04778826

Brief Summary

Any kind of anatomical lung resection for lung cancer with curative intent has to be accompanied by formal mediastinal lymph node dissection. Video-assisted mediastinoscopic lymphadenectomy through a cervical access (VAMLA) along with thoracoscopic lobectomies in the same setting offers improved radicality through bilateral mediastinal dissection, provide accurate staging, does not require single lung ventilation and hence ideally supports the concept of minimally invasive surgery. Due to the VAMLA associated radicality, the investigator believes that using of VAMLA along with lobectomy could improve the oncological outcome of lung cancer patients. Furthermore, the absence of single lung ventilation during VAMLA could attenuate the surgically induced immunosuppression.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

March 3, 2021

Status Verified

March 1, 2021

Enrollment Period

2.2 years

First QC Date

October 15, 2020

Last Update Submit

March 2, 2021

Conditions

Keywords

lung lobectomylymphadenectomy

Outcome Measures

Primary Outcomes (1)

  • postoperative interleukins

    Interleukin (IL) 6 serum concentration on the 1st postoperative day

    1st postoperative day

Secondary Outcomes (2)

  • Hospitalisation

    until discharge from hospital, assessed up to 14 days

  • Overall Survival

    5 years

Study Arms (2)

Lung Lobectomy with standard ipsilateral lymphadenectomy

ACTIVE COMPARATOR

Lung lobectomy with ipsilateral lymphadenectomy

Procedure: Lymphadenectomy

Lung Lobectomy with VAMLA

ACTIVE COMPARATOR

Lung lobectomy combined with video-assisted mediastinal lymphadenectomy through the neck (VAMLA). The approach is similar to transcervical mediastinoscopy and allows for a radical bloc dissection of all mediastinal lymph node stations. Besides the benefit of bilateral lung ventilation during this phase of the operation a bilateral mediastinal lymphadenectomy offers improved surgical radicality.

Procedure: Lymphadenectomy

Interventions

radical bloc dissection of all mediastinal lymph node stations

Lung Lobectomy with VAMLALung Lobectomy with standard ipsilateral lymphadenectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult
  • non small cell lung cancer
  • operable tumor
  • indicated for endoscopic lung surgery

You may not qualify if:

  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Thoracic Surgery, clinic Floridsdorf

Vienna, 1210, Austria

RECRUITING

Related Publications (1)

  • Salama M, Mueller MR. Enhanced recovery in lung surgery: coaxial versus conventional chest drains following video-assisted thoracoscopic surgery lobectomy-a prospective randomized trial. J Thorac Dis. 2025 Nov 30;17(11):10262-10271. doi: 10.21037/jtd-2025-1169. Epub 2025 Nov 26.

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Lymph Node Excision

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Micheal Mueller, MD

    Department of thoracic Surgery, Clinic Floridsdorf

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Compare the oncological outcome and immune competence between patients who undergo lung lobectomy with standard lymphadenectomy and those who undergo combined lobectomy and video assisted bilateral mediastinal lymphadenectomy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 15, 2020

First Posted

March 3, 2021

Study Start

October 1, 2020

Primary Completion

December 31, 2022

Study Completion

March 1, 2023

Last Updated

March 3, 2021

Record last verified: 2021-03

Locations